Agonist Guide

Author: Theo Marcell

  • Semaglutide vs Tirzepatide: A Clear GLP-1 Agonist Comparison

    By Theo Marcell (editorial pen name) · Updated September 30, 2026 · We may have a financial affiliation with some entities featured on this page. The short answer: Semaglutide activates one gut-hormone receptor (GLP-1); tirzepatide activates two (GIP and GLP-1). Both are once-weekly injectables sold under different brand names for different labeled uses. In the…

    Continue reading →

  • Zepbound vs Mounjaro: What’s Actually Different

    By Theo Marcell (editorial pen name) · Updated September 30, 2026 · We may have a financial affiliation with some entities featured on this page. The short answer: Zepbound and Mounjaro both contain tirzepatide but have separate FDA labels. As of September 2026, Zepbound is labeled for long-term weight reduction and for moderate to severe…

    Continue reading →

  • Wegovy vs Ozempic: Same Molecule, Different Indications

    By Theo Marcell (editorial pen name) · Updated September 30, 2026 · We may have a financial affiliation with some entities featured on this page. The short answer: Wegovy and Ozempic contain the same active ingredient, semaglutide, but they are separate FDA-approved products with separate labels. As of September 2026, Ozempic’s labeled uses center on…

    Continue reading →